281 related articles for article (PubMed ID: 24135137)
1. A nonclassical vitamin D receptor pathway suppresses renal fibrosis.
Ito I; Waku T; Aoki M; Abe R; Nagai Y; Watanabe T; Nakajima Y; Ohkido I; Yokoyama K; Miyachi H; Shimizu T; Murayama A; Kishimoto H; Nagasawa K; Yanagisawa J
J Clin Invest; 2013 Nov; 123(11):4579-94. PubMed ID: 24135137
[TBL] [Abstract][Full Text] [Related]
2. 1,25-(OH(2))D(3) alters the transforming growth factor beta signaling pathway in renal tissue.
Aschenbrenner JK; Sollinger HW; Becker BN; Hullett DA
J Surg Res; 2001 Oct; 100(2):171-5. PubMed ID: 11592788
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis.
Zerr P; Vollath S; Palumbo-Zerr K; Tomcik M; Huang J; Distler A; Beyer C; Dees C; Gela K; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2015 Mar; 74(3):e20. PubMed ID: 24448349
[TBL] [Abstract][Full Text] [Related]
4. HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro.
Zhao J; Wang L; Cao AL; Jiang MQ; Chen X; Wang Y; Wang YM; Wang H; Zhang XM; Peng W
Cell Physiol Biochem; 2016; 38(5):1761-74. PubMed ID: 27161221
[TBL] [Abstract][Full Text] [Related]
5. Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3.
Inoue K; Matsui I; Hamano T; Fujii N; Shimomura A; Nakano C; Kusunoki Y; Takabatake Y; Hirata M; Nishiyama A; Tsubakihara Y; Isaka Y; Rakugi H
Lab Invest; 2012 Dec; 92(12):1686-97. PubMed ID: 22926646
[TBL] [Abstract][Full Text] [Related]
6. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
7. Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway.
Dou F; Ding Y; Wang C; Duan J; Wang W; Xu H; Zhao X; Wang J; Wen A
Biochem Pharmacol; 2020 Oct; 180():114079. PubMed ID: 32511988
[TBL] [Abstract][Full Text] [Related]
8. Kindlin-2 mediates activation of TGF-β/Smad signaling and renal fibrosis.
Wei X; Xia Y; Li F; Tang Y; Nie J; Liu Y; Zhou Z; Zhang H; Hou FF
J Am Soc Nephrol; 2013 Sep; 24(9):1387-98. PubMed ID: 23723426
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta-induced dissociation between vitamin D receptor level and 1,25-dihydroxyvitamin D3 action in osteoblast-like cells.
Staal A; Birkenhäger JC; Pols HA; Buurman CJ; Vink-van Wijngaarden T; Kleinekoort WM; van den Bemd GJ; van Leeuwen JP
Bone Miner; 1994 Jul; 26(1):27-42. PubMed ID: 7950503
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
Healy KD; Zella JB; Prahl JM; DeLuca HF
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and Myofibroblasts in Fibrosis and Cancer: At Cross-purposes with TGF-β/SMAD Signaling.
Shany S; Sigal-Batikoff I; Lamprecht S
Anticancer Res; 2016 Dec; 36(12):6225-6234. PubMed ID: 27919940
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-302b mitigates renal fibrosis via inhibiting TGF-β/Smad pathway activation.
Sun M; Zhou W; Yao F; Song J; Xu Y; Deng Z; Diao H; Li S
Braz J Med Biol Res; 2021; 54(3):e9206. PubMed ID: 33503202
[TBL] [Abstract][Full Text] [Related]
14. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators.
Yanagisawa J; Yanagi Y; Masuhiro Y; Suzawa M; Watanabe M; Kashiwagi K; Toriyabe T; Kawabata M; Miyazono K; Kato S
Science; 1999 Feb; 283(5406):1317-21. PubMed ID: 10037600
[TBL] [Abstract][Full Text] [Related]
15. Lack of microRNA-155 ameliorates renal fibrosis by targeting PDE3A/TGF-β1/Smad signaling in mice with obstructive nephropathy.
Xi W; Zhao X; Wu M; Jia W; Li H
Cell Biol Int; 2018 Nov; 42(11):1523-1532. PubMed ID: 30080287
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between 1,25-dihydroxyvitamin D3 and transforming growth factor-beta signaling requires binding of VDR and Smad3 proteins to their cognate DNA recognition elements.
Subramaniam N; Leong GM; Cock TA; Flanagan JL; Fong C; Eisman JA; Kouzmenko AP
J Biol Chem; 2001 May; 276(19):15741-6. PubMed ID: 11278818
[TBL] [Abstract][Full Text] [Related]
17. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
18. Ligand-dependent actions of the vitamin D receptor are required for activation of TGF-β signaling during the inflammatory response to cutaneous injury.
Luderer HF; Nazarian RM; Zhu ED; Demay MB
Endocrinology; 2013 Jan; 154(1):16-24. PubMed ID: 23132743
[TBL] [Abstract][Full Text] [Related]
19. 1,25(OH)2D3 treatment attenuates high glucose‑induced peritoneal epithelial to mesenchymal transition in mice.
Yang L; Fan Y; Zhang X; Huang W; Ma J
Mol Med Rep; 2017 Oct; 16(4):3817-3824. PubMed ID: 28765896
[TBL] [Abstract][Full Text] [Related]
20. Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.
Chen X; Wang H; Liao HJ; Hu W; Gewin L; Mernaugh G; Zhang S; Zhang ZY; Vega-Montoto L; Vanacore RM; Fässler R; Zent R; Pozzi A
J Clin Invest; 2014 Aug; 124(8):3295-310. PubMed ID: 24983314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
